Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment

By sjmartinez • June 28, 2023

Gilham D, Wasiak S, Rakai BD, Fu L, Tsujikawa LM, Sarsons CD, Carestia A, Lebioda K, Johansson JO, Sweeney M, Kalantar-Zadeh K, Kulikowski E. Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment. Biomedicines. 2023 Jun 8;11(6):1663. doi: 10.3390/biomedicines11061663. PMID: 37371758.

Tags: apabetalone, BET proteins, chronic kidney disease (CKD), epigenetics, fibrosis, gene expression, Harbor UCLA, Inflammation, Nephrology, Publications

Pulmonary Obstruction and Age, Not Activity, Associate With Muscle Oxidative Impairment in Smokers With and Without COPD

Adami A, Duan F, Calmelat RA, Chen Z, Casaburi R, Rossiter HB. Pulmonary Obstruction and Age, Not Activity, Associate With Muscle Oxidative Impairment in Smokers[...]

Trends in Mortality Associated With Ischemic Heart Disease and Screenable Cancers in the United States, 1999 to 2024

Rana JS, Mszar R, Gianos E, Budoff MJ, Nasir K, Ahmed M. Trends in Mortality Associated With Ischemic Heart Disease and Screenable Cancers in the[...]

CDK4/6 Inhibition in the Management of Metastatic HR+/HER2+ Breast Cancer: Systematic Review and Meta-analysis

Park D, Varda M, Yeremian S, Hwang A, Huang C. CDK4/6 Inhibition in the Management of Metastatic HR+/HER2+ Breast Cancer: Systematic Review and Meta-analysis. Target[...]